FTO and obesity due to melanocortin 4 receptor deficiency: Furthermore, a meta-analysis of multiple studies across various ethnic groups emphasizes that FTO’s role in breast cancer risk is often mediated by factors like obesity, estrogen receptor status, and metabolic health (42).